Basel Medical Receives Nasdaq Delinquency Notice
Ticker: BMGL · Form: 6-K · Filed: Dec 1, 2025 · CIK: 2004489
| Field | Detail |
|---|---|
| Company | Basel Medical Group LTD (BMGL) |
| Form Type | 6-K |
| Filed Date | Dec 1, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, delinquency-notice, sec-filing
TL;DR
Nasdaq sent Basel Medical a delinquency notice, might be trouble.
AI Summary
Basel Medical Group Ltd. filed a Form 6-K on December 1, 2025, reporting the receipt of a delinquency notification from Nasdaq. The company's principal executive office is located at 6 Napier Road, Unit #02-10/11 Gleneagles Medical Centre, Singapore. The filing indicates that the company is subject to the reporting requirements of the Securities Exchange Act of 1934.
Why It Matters
This notification from Nasdaq could impact the company's stock trading status and investor confidence.
Risk Assessment
Risk Level: medium — Receiving a delinquency notification from a stock exchange like Nasdaq indicates potential non-compliance with listing requirements, which poses a risk to the company's market status.
Key Players & Entities
- Basel Medical Group Ltd (company) — Registrant
- Nasdaq (company) — Exchange where delinquency notice was received
- Dr. Darren Yen Feng Chhoa (person) — Chief Executive Officer
- December 1, 2025 (date) — Filing date
- November 2025 (date) — Reporting period
FAQ
What is the specific reason for the Nasdaq delinquency notification?
The filing does not specify the exact reason for the delinquency notification from Nasdaq, only that it was received.
What is Basel Medical Group Ltd.'s principal executive office address?
Basel Medical Group Ltd.'s principal executive office is located at 6 Napier Road, Unit #02-10/11 Gleneagles Medical Centre, Singapore 258499.
When was this Form 6-K filed?
This Form 6-K was filed on December 1, 2025.
Who signed the report on behalf of Basel Medical Group Ltd?
Dr. Darren Yen Feng Chhoa, Chief Executive Officer, signed the report on behalf of Basel Medical Group Ltd.
Does Basel Medical Group Ltd. file annual reports under Form 20-F or 40-F?
Basel Medical Group Ltd. files annual reports under Form 20-F, as indicated by the checkmark next to 'Form 20-F'.
Filing Stats: 153 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2025-12-01 17:00:26
Filing Documents
- form6-k.htm (6-K) — 15KB
- ex99-1.htm (EX-99.1) — 8KB
- 0001493152-25-025588.txt ( ) — 25KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Basel Medical Group Ltd By: /s/ Darren Yen Feng Chhoa Name: Dr. Darren Yen Feng Chhoa Title: Chief Executive Officer Date: December 1, 2025